JPMorgan analyst Harlan Sur raised his price target on Lam Research (NASDAQ:LRCX | LRCX Price Prediction) stock to $315 from $300 and reiterated an Overweight rating, arguing that the latest earnings report has reset both the near-term bar and the multi-year wafer fab equipment (WFE) framework. Lam Research now sits at the center of a widening analyst upgrade cycle tied directly to AI-driven chip demand. For long-term investors, the revised outlook warrants a closer look, even as valuation remains stretched.
Goldman Sachs joined the chorus the same morning, raising its price target on Lam Research stock to $290 from $262 with a Buy rating. Two top-tier firms lifting targets in tandem is the kind of signal retirement-focused investors tend to watch closely.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| LRCX | Lam Research | JPMorgan | Price target raised | Overweight | Overweight | $300 | $315 |
| LRCX | Lam Research | Goldman Sachs | Price target raised | Buy | Buy | $262 | $290 |
The Analyst’s Case
Sur’s thesis centers on visibility. JPMorgan argues the March-quarter print extends the multi-year WFE framework into 2027 and 2028 for Lam Research, transforming what looked like a cyclical bounce into a durable spending wave. Goldman’s note echoes that view, citing an improved calendar-2026 WFE outlook of roughly $140 billion driven by broad demand.
The nuance investors should appreciate: near-term shipments are actually being capped by cleanroom constraints, yet both firms view that bottleneck as a genuine demand signal. Goldman explicitly says Lam Research is “well positioned for outperformance” thanks to deposition, etch, and NAND upgrade cycle exposure, with stronger growth potential into CY27.
Company Snapshot
Lam Research designs and services the deposition and etch tools that sit at the heart of every advanced chip fab. In the March quarter, revenue hit a record $5.84 billion, up 24% year over year, with non-GAAP EPS of $1.47 beating the $1.36 consensus.
Lam Research CEO Tim Archer framed the backdrop directly: “Lam delivered record revenue and EPS in the March quarter as AI-driven demand reshapes the semiconductor industry.” Guidance for the June quarter calls for revenue of $6.6 billion plus or minus $400 million and EPS of $1.65.
Why the Move Matters Now
Lam Research stock trades at a trailing P/E ratio of 55x and a forward P/E ratio of 38x, multiples that only make sense if the supercycle thesis holds. Analyst conviction is broad: 27 Buy or Strong Buy ratings versus 9 Hold and zero Sell.
Our recent coverage of semiconductor capex trends underscores how HBM, DRAM, and NAND upgrade spend are converging. The JPMorgan target of $315 sits above the consensus target of $281.23, positioning it as an aggressive bull case rather than a mainstream view.
What It Means for Your Portfolio
For retirement-focused investors, Lam Research stock offers pure-play exposure to a multi-year equipment cycle backed by four consecutive EPS beats and expanding operating margins. The capital return profile, including $1.16 billion of buybacks in the March quarter, provides additional shareholder support.
The bearish counterweight is real: China represented $1.99 billion of Q3 revenue, leaving Lam Research exposed to export controls and tariffs. A measured position size, rather than a full commitment, may be the prudent path as the supercycle narrative plays out.
Top Gaining Stocks
Top Losing Stocks